Duration of antibody responses after severe acute respiratory syndrome

Emerging Infectious Diseases

Volumn 13, Issue 10, 2007, Pages 1562-1564

  Wu, Li Ping ^a   Wang, Nai Chang ^a   Chang, Yi Hua ^a   Tian, Xiang Yi ^a   Na, Dan Yu ^a   Zhang, Li Yuan ^a   Zheng, Lei ^a   Lan, Tao ^b   Wang, Lin Fa ^c   Liang, Guo Dong ^d,e  

^a Shanxi Provincial Center for Disease Control and Prevention   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c CSIRO   (Australia)

^d State Key Laboratory for Infectious Disease Prevention and Control   (China)

^e Institute for Viral Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; OPTICAL DENSITY; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 35548934673     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1310.070576     Document Type: Article

References (15)

1. Peiris JSM, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004;10:S88-97.
2. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276-9.
3. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A. 2005;102:2430-5.
4. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310:676-9.
5. Lau SKP, Woo PCY, Li KSM, Huang Y, Tsoi HW, Wong BHL, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A. 2005;102:14040-5.
6. Wang L-F, Shi Z, Zhang S, Field H, Daszak P, Eaton BT. Review of bats and SARS. Emerg Infect Dis. 2006;12:1834-40.
7. Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest. 2003;111:1605-9.
8. World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Revised 1 May 2003. [cited 2007 Jul 23]. Available from http://www.who.int/csr/sars/casedefinition/en
9. Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis. 2004;190:1119-26.
10. Liu W, Fontanet A, Zhang PH, Zhan L, Xin ZT, Baril L, et al. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis. 2006;193:792-5.
11. Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006;11:49-53.
12. Woo PC, Lau SK, Wong BH, Chan KH, Chu CM, Tsoi HW, et al. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004;11:665-8.
13. Chang SC, Wang JT, Huang LM, Chen YC, Fang CT, Sheng WH, et al. Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients. Clin Diagn Lab Immunol. 2005;12:1455-7.
14. Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, et al. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis. 2005;11:411-6.
15. He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J Immunol. 2006;176:6085-92.